CLOVER CORPORATION LIMITED (CLV)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
CLV - CLOVER CORPORATION LIMITED
FNArena Sector :
Health & Nutrition
Year End: July
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 2.42
Index:
FNArena Sector : Health & Nutrition
Year End: July
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 2.42
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$0.515
01 Nov |
0.000 OPEN $0.52 |
0.000 HIGH $0.52 |
100,462 LOW $0.51 |
OTHER COMPANIES IN THE SAME SECTOR | |||
EBO . EXL . MCP . SIG . |
FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
Last ex-div: 30/10 - ex-div 0.75c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | 0.9 |
DPS All | xxx | xxx | xxx | xxx | xxx | 0.8 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 62.2 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 40.2 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 8.5 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | 2.44 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | 2.26 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | 2.02 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | 1.78 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | 2.26 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 4.00 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | 4.9 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 4 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 7 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 10 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | 2 M |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 12 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 1.22 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 2.3 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 3.74 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 45 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 14 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | 2 M |
Investments - Total | xxx | xxx | xxx | xxx | xxx | 11 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
EXTRA COVERAGE
Display All Commentary
No. Of Recommendations
Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.
CLV STOCK CHART
FNArena News on CLV
1 |
Australian Broker Call *Extra* Edition – Oct 08, 2024Oct 08 2024 - Daily Market Reports |
2 |
In Case You Missed It – BC Extra Upgrades & Downgrades – 12-04-24Apr 12 2024 - Weekly Reports |
3 |
Australian Broker Call *Extra* Edition – Apr 08, 2024Apr 08 2024 - Daily Market Reports |
4 |
FNArena Corporate Results Monitor – 22-03-2024Mar 22 2024 - Australia |
5 |
Australian Broker Call *Extra* Edition – Mar 20, 2024Mar 20 2024 - Daily Market Reports |
Latest Health & Nutrition News
1 |
Sigma Healthcare Promises Higher MarginsOct 03 2023 - Small Caps |
2 |
Sigma’s Win Not Neccessarily Ebos’ LossJun 14 2023 - Small Caps |
3 |
Sigma Healthcare: Brokers WaryMar 31 2022 - Australia |
4 |
Health & Wellness Boom On The ASXApr 29 2021 - Weekly Reports |
5 |
M&A Now On Sigma Healthcare’s AgendaMar 24 2021 - Australia |
6 |
McPherson’s Expands Into Herbal HealthNov 04 2020 - Small Caps |
7 |
Nine Ignored Companies Now Worth A LookSep 23 2020 - FYI |
8 |
Next Week At A Glance – 14-18 Sep 2020Sep 11 2020 - Weekly Reports |
9 |
Sigma Farewells API, Heralds New ContractDec 17 2019 - Australia |
10 |
Blackmores: Hopes Pinned On RestructuringNov 01 2019 - Australia |